書籍詳細

特別寄稿

P.7 掲載の参考文献

• 1) Droge W and Hoim E: Role of cysteine and glutathione in HIV infection and other diseases associated with muscle wasting and immunological dysfunction. FASEB J. 11: 1077-1089, 1997.

• 2) Fernandes-Checa J, Kaplowitz N, Garcia-Ruiz C, et al: GSH transport in mitochondria: defense against TNF-induced oxidative stress and alcohol-induced defect. Am. J. Physiol. 273: G7-G17, 1997.

• 3) Lu SC, Sun W-E, Ookhtens M. et al: Role of two recently cloned rat live GSH transporters in the ubiquitous, transport of GSH in mammalian cells. J. Clin. Invest. 97: 1488-1496, 1996.

• 4) Hwang C, Sinskey AJ and Lodish HF: Oxidized redox state of glutathione in the endoplasmic reticulum. Science 257: 1496-1502, 1992.
  pubmed

• 5) Carelli S, Ceriotti A, Cabibbo A, et al: Cysteine and glutathione secretion in response to protein disulfide bound formation in the ER. Science 277: 1681-1684, 1997.

• 6) Rokutan K, Hirakawa T, Teshima S, et al: Glutathione depletion impairs trangscriptional activation of heat shock genes in primary cultures of guinea pig gastric mucosal cells. J. Clin., Invest. 97: 2242-2250, 1996.

• 7) Droge W, Schuhz-Osthoft K, Mihm S, et al: Functions of glutathione and glutathione disulfide in immunology and immunopathology. FASEB J. 8: 1131-1138, 1994.

• 8) Kroemer G, Zamzami N and Susin SA: Mitochondrial control of apoptosis. Immunol. Today 18 : 44-51, 1997.
  pubmed

• 9) van den Dobbelsteen DJ, Nobel CSI, Schlege J, et al: Rapid and specific efflux of reduced glutathione during apoptosis induced by anti-Fas APO-1 anti-body. J. Biol. Chem. 271: 15420-15427,1 996.

• 10) Ghibelli L, Fanelli C, Rotilio G, et al: Rescue of cells from apoptosis by inhibition of active GSH extrusion. FASEB J.12: 479-486,1998.
  pubmed

• 11) Cotgreave L and Gerdes RG: Recent trands in glutathione biochemistry-glutathione-protein interactions: a molecular link between oxidative stress and cell proliferation? Biochem. Biophys. Res. Commun. 242: 1-9, 1998.

Session 胃1

P.12 掲載の参考文献

• 1) Robert A, Nezamis JE, Lancaster C, et al: Cytoprotection by prostaglandins in rats. Gastroenterology 77: 433-443, 1979.
  pubmed

• 2) Robert A, Nezamis JE and Philips JP: Inhibinon of gastric secretion by prostaglandins. Am. J. Digest Dis. 12: 1073-1075, 1967.

• 3) Takeuchi K and Okabe S: Gastroduodenal bicarbonate secretion: Pharmacological modulation and contribution to mucosal protection (edited by Gaginella TS), CRC Press, Boca Raton, 1995, pp.1-26.

• 4) Coleman RA, Smith WL and Narumiya S: International union of pharmacology classification of prostanoid receptors: Properties, distribution, and structure of the receptors and their subtypes. Pharmacol. Rev. 46: 205-229, 1994.
  pubmed

• 5) Takeuchi K, Magee D, Critchlow J. et al: Study of the pH gradient and thickness of frog gastric mucus gel Gastroenterology 84: 331-340, 1983.

• 6) Namba T, Sugimoto Y, Negishi M, et al: Alternative splicing of C-terminal tail of prostaglandin E receptor subtype EP3 determines G-protein specificity. Nature 365: 166-170, 1993.
  pubmed

P.16 掲載の参考文献

• 1) Hant C and Morimoto RI: Conserved features ofeukaryotic hsp70 gcnes revealed by comparison with the nucleotide sequence of human hsp70. Proc. Natl Acad. Sci. USA 82: 6455-6459, 1985.

• 2) Nakamura K, Rokutan K, Marui N, et al: Induction of heat shock proteins and their implication against ethanol-induced damage in cultured guinea pig gastric mucosal cells. Gastroenterology 101: 161-166, 1991.
  pubmed

• 3) Hirakawa T, Rokutan K, Kishi K. et al: Geranylgeranylacetone induces heat shock protci ll s, in cultured guinea pig gastric mucosal cells and rat gastric mucosa. Gastroenterology 111: 345-357, 1996,

• 4) Minowada G and Welch WJ: Clinical implications of stress response. J. Clin. Invest. 95: 3-12, 1995.
  pubmed

• 5) Hendric JP and Hartl FU: Molccular chaperon functions of the heat shock proteins. Annu. Rev. Biochem. 62: 349-384, 1993.

• 6) Suzuki K, Sawa Y, Matsuda H. et al: In vivo gene transfection with heat shock protein 70 enhances myocardial tolerance to Ischemia-reperfusion injury in rat. J. Clin. Invest. 99: 1645-1650,1997.

• 7) Morimoto RI, Sarge KD, Abravaya K. et al: Transcriptional regulation of heat syock genes. J. Biol. Chem. 267: 21987-21990, 1992.

P.21 掲載の参考文献

• 1) Vane JR, Mitchell JA, Appleton L et al: Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation.Proc. Natl Acad. Sci. USA 91: 2046-2050, 1994.

• 2) Takeuchi K, Ueshima K, Ohuchi T, et al: Role of capsaicin-sensitive sensory neurons in healing of HCI-induced gastric mucosal lesions in rats. Gastroenterology 106: 1524-1532, 1994.

• 3) Futaki N, Takahashi S, Yokoyama M, et al: NS-398. a new anti-inflammatory agent, selectively inhibits prostaglandin G /H synthase/ cyclooxygenase (COX-2) activity in vitro itro. Prostaglandins 47: 55-59, 1994.

• 4) Nakatsugi S, Terada N, Yoshimura T, et al: Effects of nimesulide, a preferential cyclooxygenase-2 inhibitor, on carrageenan-induced pleurisy and stress-induced gastric lesions in rats.Prostaglandins Leuko. Essent. Fatty Acids 55: 395-402, 1996.

• 5) Takeuchi K. Furukawa O, Tanaka H. et al: A new model of duodenal ulcers induced in rats by indomethacinplus histamine. Gastroenterology 90: 636-645, 1986.

• 6) Whinle BJR: The potentiation of taurocholate-induced rat gastric erosions following parenteral administration of cyclooxygenase inhibitors. Br.J. Pharmacol. 80: 545-551, 1983.

• 7) Silen W: Gastric mucosal defense and repair. In Physiology of the gastrointestinal tract (edited by Johnson LR. Christensen J. Grossman MI, et al), Raven Press, New York,1987, pp.1055-1069.

• 8) Takeuchi K, Tanaka H, Furukawa O, et al: Gastroduodenal HCO3 secretion in anesthetized rats: Effects of 16-dimethyl PGE2, topical acid and aceta-zolalllide. Jpn. J.Pharmacol. 41: 87-100, 1986.

• 9) Ahlquist D, Dozois PR, Zinzmeister AR, et al: Duodenal prostaglandin systhesis after acid load in heahh and in duodenal ulcer diseases. Gastroenterology 85: 522-528, 1983.

P.25 掲載の参考文献

• 1) Ito T, Hayashi N, Sasaki Y, et al: Sequential protooncogene expression during regeneration in ratstoniach. Gastroenterology 98:1 1525-1531, 1990.

• 2) Sawaoka H, Tsuji S, Kawano S. et al: Expresslon of cyclooxygenase-2 and other immediate early genesin rat gastric mucosa in ulcer healing. Gastroenterology 108 (Suppl. 4) : A211, 1995.

• 3) Whittle BJR, Lopez-Belmonte J and Moncada S: Regulation of gastric mucosal integrity by endogenous nitric oxide: interactions with prostanoids and scnsory neuropeptide: in the rat. Br. J. Pharmacol. 99: 607-611, 1990.

• 4) Tsuji S, Kawano S, Sasayama Y, et al: Gastric mucosal cell proliferation and TGF αi n the healing of peptic ulcers in human subjects. J. Clin. Gastroenterol. 21 (Suppl. 1) : S30-S35, 1995.

• 5) Ohno T, Ohtsuki H, Okabe S, et al: Effects of 16, 16-dimethyl prostaglandin E2 on ethanol-induced and aspirin-induced gastric damage in the rat. Gastroenterology 88: 353-361, 1985.
  pubmed

P.29 掲載の参考文献

• 1) Kanno Y and Matui Y: Cellular uncoupling in cancerous stomach epithelium. Nature 218: 775-776, 1968.

• 2) Kyoi T, Ueda F, Kimura K. et al: Development of gap junctions between gastric surface mucosa cells during cell maturation in rats. Gastroenterolog 102: 1930-1935, 1992.

• 3) Mine T, Yas uda H, Kataoka A. et al: Human chronic gastric ulcer and connexin. J. Clin. Gastroenterol. 21: S104-S107, 1995.

• 4) Mine T, Kushima R and Fujita T: Relationship between healing of acetic acid-induced chronic gastric ulcer and connexin. J. Clin. Gastroenterol. 25: S111-S115, 1997.

• 5) Correa P, Haenszel W, Cuello C, et al: Gastric pre-cancerous process in a high risk population: cross sectional studies. Cancer Res.50: 4731-4736, 1990.

P.33 掲載の参考文献

• 1) 和田哲成, 長畑洋司, 安積靖友・他: 複雑性イレウスにおける血管凝固因子の検討.神戸大医紀 57: 1-9, 1996.

• 2) 和田哲成, 長畑洋司, 安積靖友・他: ラットにおける新しいイレウスモデルの作成.日消外会誌 27: 1870, 1994.

• 3) Neilly PJD, Gardiner KR, Kirk SJ, et al: Endotoxaemia and cytokine production in experimental colitis. Br. J. Surg.82 : 1479-1482 ,1995.

• 4) 平田公一: エンドトキシン血症,DICとSIRS. 消化器外科 18: 193-199, 1995.

P.36 掲載の参考文献

• 1) 吉田憲正, 山口泰司, 杉本尚仁・他: TNB惹起性大腸炎における接着分子ICAM-1の役割. Prog. Med.17: 1959-1961, 1997.
  Medical*Online

• 2) Morris G,, Beck PL, Herridge MS. et al: Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 96: 795-803, 1989.
  pubmed

• 3) Ohkawa H, Ohishi N and Yagi K: Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 95: 351-358, 1979.
  pubmed

• 4) Krawisz JE, Sharon P and Stenson WF: Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Gastroenterology 87: 1344-1350, 1984.
  pubmed

• 5) Yoshida N, Granger DN, Evans DJ, et al: Mechanisms involved in Helicobacter pylori-induced inflammation, Gastroenterology 105: 1431-1440, 1993.
  pubmed

• 6) Yoshida N, Yoshikawa T, Nakamura Y, et al: Role of neutrophil-mediated inflammation in aspirin-induced gastric mucosal injury. Dig. Dis. Sci. 40: 2300-2304, 1995.
  pubmed

• 7) Schurmann GM, Bishop AE. Facer P, et al: Increased expression of cell adhesion molecule P-selectin in active inflammatory bowel disease. Gut 36: 411-418, 1995.
  pubmed

• 8) Tojo SJ, Yokota S, Koike H, et al: Reduction of rat myocardial ischemia and reperfusion injury by sialyl Lewis x oligosaccharide and anti-rat P-setectin antibodies. Glycobiology 6: 463-469, 1996.

• 9) Ohnishi M, Koike H. Kawamura N, et al: Role of P-selectin in the early stage of the Arthus reaction. Immunopharmacology 34: 161-170, 1996.
  pubmed

• 10) 吉田憲正, 吉川敏一, 山口泰司・他:ラットTNB惹起性大腸炎における活性酸素の関与. Prog. Med. 16: 2479-2482, 1996
  Medical*Online

P.38 掲載の参考文献

• 1) Evans Mj and Scarpulla RC: Both upstrcam and intron sequencc clemcnts are rcquired for elevated expression of the rat sonlatic cytochrome c gene in COS-1 cells. Mol. Cell. Biol 8: 35-41, 1988.
  pubmed

• 2) Evans MJ and Scarpulla RC: NRF-1: A trans-activator of nuclear-encoded respiratory genes in animal cells. Genes Dev. 4: 1023-1034, 1990.
  pubmed

• 3) Chau CA, Evans MJ and Scarpulla RC: Nuclear respiratory factor l activation sites in gecnes encoding the gamma-subunit ATP: synthase, eukaryotic initiation factor 2 a, and tyrosille alninotrans ferase. Specific interaction of purified NRF-1 with multiple target genes. J. Biol. Chem. 267: 6999-7006, 1992.

• 4) Clayton DA: Transcription and replication of animal mitochondrial DNAs. Int. Rev. Cytol. 141: 217-232, 1992.
  pubmed

• 5) Shadel GS and Clayton DA: Mitochondrial transcription initiation. Variation and conservation. J. Biol. Chem. 268: 16083-16086, 1993.
  pubmed

• 6) Murakami T, Shimomura Y, YoshimLira A. et al: Induction of nuclear respiratory factor-1 expression by an acute bout of exercise in rat muscle. Biochim. Biophys. Acta 1381: 113-122, 1998.
  pubmed

P.41 掲載の参考文献

• 1) Poupon R, Poupon RE, Calmus Y, et al: Is ursodeoxycholic acid an effective treatment for primary biliary cirrhosis? Lancet 1: 834-836, 1987.

• 2) 美馬聡昭, 関谷千尋, 金川博史・他: 自己免疫 性肝炎におけるウルソデオキシコール酸の効果. 肝臓 34: 849-850,1993.

• 3) Takano S, Ito Y, Yokosuka O, et al: A multicenter rando)mized controlled dose study of ursodeoxy-cholic acid for chronic hepatitis C. Hepatology 20: 558-564, 1994.

• 4) Mitsuyoshi H, Nakashima T, Inaba K, et al: Ursodeoxycholic acid decreases the serum transaminase levels of chronic liver disease patients treated with glycyrrhizin. Int. Hepatol Commun. 6: 85-91, 1996.

• 5) 中嶋俊彰, 光吉博則, 稲葉弘二・他: 慢性肝疾患におけるUDCAとグリチルリチン製剤の併用効果について.Cyto-protection & biology 14: 51-53, 1996.

• 6) Tanaka H and Makino I: Ursodeoxycholic acid-dependent activation of glucocorticoid receptor. Biochem. Biophss. Res. Commun.188: 942-948, 1992.
  pubmed

• 7) Bouscarel B, Fromm H and Nussbaum R: Ursodeoxycholate mobilizes intracellular Ca2+ and activates phosphorylase a in isolated hepatocytes. Am. J. Physiol. 264: G243-G251, 1993.
  pubmed

• 8) Bouscarel B, Gettys TW, Fromm H, et al: Ursodeoxycholic acid inhibits glucagon-induced cAMP formation in hamster hepatocytes: a role for PKC. Am. J. Physiol.268: G300-G310, 1995.
  pubmed

• 9) Beuers U, Throckmorton DC, Anderson MS, et al: Tauroursodeoxycholic acid activates protein kinase C in isolated rat hepatocytes. Gastroenterology 110: 1553-1563, 1996.
  pubmed

• 10) 中嶋俊彰: 慢性肝炎の管理と治療 薬物療法-肝庇護剤の意義. 肝炎-C型肝炎の新展開(鈴木 宏・編), 改訂第3版,南江堂,東京, 1995, pp127-134.

P.46 掲載の参考文献

• 1) 長谷川忠,中野 稔,桜井敏雄・他: O2産生能からみた敗血症肝障害における脾臓の役割. Cyto-protection & biolog 14: 91-94,1996.

• 2) Ferluga J and Allison AC: Role of mononuclear infiltrating cells in pathogenesis of hepatitis. Lancet 16: 610-611, 1978.

• 3) Uehara K, Maruyama N, Nakano M, et al: The first application of chemiluminescence probe. 2-methyl-6-[p-methoxyphenyl]-3, 7-dihydroimidazo [1,2-a] pyrazin-3-one (MCLA), for detecting O2 production, in vitro, from Kupffer cells stimulated by phorbol myristate acetate. FEBS Lett.335: 167-170, 1993.
  pubmed

• 4) Nakano M, Kikuyama M, Hasegawa T. et al: The first observation of O2 generation at real time in vivo from non-Kupffer sinusoidal cells in perfused rat liver during acute ethanol intoxication. FEBS Lett. 372: 140-143, 1995.
  pubmed

• 5) Koga S and Nakano M: A high involvement of O2 possibly generated in inner membranes for iron-induced microsomal lipid peroxidation. Biochem. Biopyhs. Res. Commun. 186: 1087-1093, 1992.

P.50 掲載の参考文献

• 1) Palmer RMJ, Ferrige AG and Moncada S: Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327: 524-526, 1987.

• 2) Inoue M. Minamiyama Y and Takemura S: Dynamic Aspectg. of Nitric Oxide Metabolism in The Circulation and Tissues.Methods Enzymol. 269: 474-479, 1996.
  pubmed

• 3) Takemura S, Minamiyama Y, Kinoshita H ct al: Dynamic aspects and role of nitric oxide in endotoxin-induced liver injury. ln The Biology of Nitric Oxide Part 5 (edited by Moncada S, Stamler J, Gross S. Higgs EA). Portland Press, London. 1996, p.277.

• 4) Minamiyama Y, Takemura S, lmaoka S, et al: Irreversible inhibition of cytochrome P450 by nitric oxide.J. Pharmacol. Exp). Ther.283: 1479-1485, 1997.
  pubmed

P.53 掲載の参考文献

• 1) Ikeda Y alld Long DM: The niolecular basis of brain imjury and brain edema: The role or oxygen free radicals. Neurosurgey 27: 1-11, 1990.

• 2) Kukrcja RC Jcsse RL alld Hess ML: Singlet oxygen: a potential culprit in myocardial injury? Moll. Cell. Biochem 111: 17-24.1992.

• 3) Mizukawa H and Okabe E: Inhibition by singlet molecular oxygen of the vascular reactivity in rabbit mesenteric artery. Br. J. Pharmacol. 121 : 63-70, 1997.
  pubmed

• 4) 竹内 功, 高島一敏, 川合明彦・他: Histidineの細胞緩衝作用を利用した心保存液による犬心の長時間保存.日胸外会誌 43 :1895-1901, 1995.

• 5) 川本俊樹, 池田幸穂, 寺本 明: ラット一過性前脳虚血時におけるL-histidine (singlet oxygen scavenger)の脳保護効果.脳と神経 49:612-618, 1997.

• 6) Fadel MM. Foley PL, Kassell NF. et al: L-histidine attenuates cerebral vasospasm in a rabbit model of subarachnoid hemorrhage. Surg. Neurol. 143: 52-58, 1995.

P.57 掲載の参考文献

• 1) 厳 淳讃, 鈴木茂彦, 西村義彦: 皮弁生着メカニズムにおけるNOの関与. Cyto-protection & biology 14: 87-90, 1996.

• 2) Beckman JS. Beckman TW, Chen J, et al: Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide.Proc. Natl Acad. Sci. USA 87: 1620-1624, 1990.
  pubmed

• 3) Uchida K, Szweda LI, Chae HZ, et al: Immuno-chemical detection of 4-hydroxy-nonenal protein adducts in oxidized hepatocytes. Proc. Natl Acad. Sci. USA 90: 8742-8746, 1993.

• 4) Kaur H and Halliwell B: Evidence for nitric oxide-mediated oxidative damage in chronic inflmation, Nitrotyrosine in serum and synovial fluid from rheumatoid patients. FEBS Lett.350 : 9-12,1 994.

• 5) Toyokuni S, Uchida K, Okamoto K, et al: Formation of 4mhydroxym 2 nonenal modified proteins in the renal proximal tubules of rats treated with a renal carcinogen, ferric nitrilotriacetate. Proc. Natl Acad. Sci. USA 91: 2616-2620, 1994.
  pubmed

• 6) Wang P and Jweier JL : Measurement of nitric oxide and peroxynitrite generation in the postischemic heart.. J. Biol Che 1. 271: 29223-29230, 1996.

• 7) Johnson G III,Tsao PS and Lefer AM : Cardio-protective effects of authentic nitric oxide in myocardial ischemia with reperfusion. Crit. Care Med.19: 244-252, 1991.

• 8) Harashina T. Sawada Y and Watanabe S: The relationship between venous occlusion time in island flaps and flap survival. Plast. Reconstr. Surg. 60: 92-95, 1977.
  pubmed

P.62 掲載の参考文献

• 1) 諸岡 弘: 脳梗塞再発予防に対する最適抗血小板薬の検討. Cyto-ptotection & biology 14: 67-70, 1996.

• 2) 諸岡 弘: 脳梗塞時の血小板凝集活性化に及ぼす交感神経の役割. Cyto-ptotection & biology 15: 71-74, 1997.

• 3) Hecker G, Utz J, Kupferschmidt RJ, ct al: Low levels of hydrogen peroxide ellhance platelet aggregation by cyclooxygenase activation. Eicosanoids 4: 107-113, 1991.

• 4) Test ST and weiss SJ: Quantitative and temporal characterization of the extracellular H2O2 pool generated by human neutrophils. J. Biol. Chem. 259: 399-405, 1984.

• 5) 大石 誠子: 過酸化脂質測定法.最新医 33: 8-11, 1978.

• 6) Donnelly CH: Substrate-and inhibitor-related characteristics of human platelet monoamine oxidase. Biochem. Pharmacol 1. 26: 853-858, 1977.

• 7) Iuliano L, Pratico D, Bonavita MS, et al: Involvement of phospholipase A2-dependent platelet activation. Platelets 2: 87-90, 1992.

• 8)Satrustegui J and Richter C: Thc role of hydroper-oxides as calcium release agents in rat brain mitochondria. Arch. Biochem. Biophys. 233: 736-740, 1984.

P.65 掲載の参考文献

• 1) Chervu A and Moore WS: An overview of intimal hyperplasia. Surg. Gynecol. Obstett. 171: 433, 1990.
  pubmed

• 2) Libby P, Schwartz D, Brogi E, et al: A cascade model for restenosis: a special case of atherosclerotic progregesion. Circulation 86 (Suppl III) : 47-52, 1992.

• 3) Libby P, Marin ML Lyon RT. et al: Immunolocalization and temporal distribution of cytokine expression during the development of vein graft intimal hyperplasia in an experimental model. J. Vasc. Surg 24: 463-471,1996.

• 4) Kancgae Y, Makimura M and Saito l: A simple and efficicnt mcthod for purification of infectious recom binant adenovirus. Jpn. J. Med. Sci. Biol. 47: 157-166, 1994.

• 5) Zwolac RM, Adams MC and Clowes AW: Kinetics of vein graft hyperplasia: association with tangential stress. J. Vasc. Surg. 5 : 126-136, 1987.

• 6) Clowes AW: Pathologic intimal hyperplasia as a response to vascular injury and reconstruction. In Vascular Surgery (edited by Rutherford RB) .WB Saundcrs Co., Philadelphia, 1989, pp.266-275.

• 7) Warner SJC. Auger KR and Libby P: Interleukin-1 induces interleukin l. II .Recombinant human inter-leukin 1 induces interleukin 1 production by adult human vascular endothelial cells. J. Immunol. 139: 1911-1917,1987.

• 8) Raincs EW, Dower SK and Ross R: Interleukin-1 mitogenic activity for fibroblasts and smooth muscle cells is due to PDGF-AA. Science 243: 393-396, 1989.

• 9) Nawroth PP, Handley DA. Esmon CT. et al: Interleukin-1induces endothelial cell procoagulant while suppressing cell surface anticoagulant activity. 1 Proc. Natl Acad. Sci. USA 83: 3460-3464, 1986.
  pubmed

• 10) Bussolino F, Breviario F, Tetta C, et al: Interleukin

P.71 掲載の参考文献

• 1) Reed JC: Bcl-2 and the regulation of programmed cell death. J. Cell. Biol.124: 1-6, 1994.
  pubmed

• 2) 浦 正幸, 山田 武: アポトーシス.Bio Science用語ライブラリー.実験医学別冊,羊土社, 1996.

• 3) Kerr JFR, Harmon B and Searle J: An electron-microscope study of cell deletion in the anuran tadpole tail during spontaneous metamorphosis with special reference to apoptosis of striated muscle fibres.J. Cell Sci.14: 571-585,1974.

• 4) Burggren WW and West NH: Changing respiratory importance of gills,lung and skin during metamorphosis in the bullfrog Rana catesheiana. Respir. Physiol.4 7: 151-164, 1982.
  pubmed

• 5) Dodd MHI and Dodd JM: The biology of metamorphosis. In Physiology of the Amphiba (edited by Lofts B) ,New York, San Francisco. London. Academic Press,1976, pp.467-599.

• 6) Brown DD, Wang Z, Furlow JD, et al: The thyroid hormone-induced tail resoroption program during Xenopus laevis metamorphosis. Proc. Natl Acad. Sci. USA 93: 1924-1929, 1996.
  pubmed

• 7) Kashiwagi A: Peroxisomal enzyme activity changes in the tail of anuran tadpoles during metamorphosis. Comp Biochem. Physiol B. Biochem Mol. Biol.111: 483-489 ,1995.
  pubmed

• 8) Hanada H, Kashiwagi A, Takehara Y, et al: Do reactlve oxygen species underlie the mechanism of apoptosis in the tadpole tai1? Free Radic. Biol Med. 23: 294-301, 1997.

• 9) Wood KS. Buga GM, Byrns RE, et al: Vascular smooth muscle-derived relaxing factor(MDRF)and its close similarity to nitric oxide. Biochem. Biophys. Res. Commun. 170 : 80-88, 1990.
  pubmed

• 10) Drown GC: Reversible binding and inhibition of catalase by nitric oxide. Eur. J. Biochem.232: 188-191, 1995.

• 11) Takehara Y, Nakahara H, Inai Y, et al: Oxygen-dependent reversible inhibition of mitochondrial respiration by nitric oxide. Cell Struct Func.21 : 251-258, 1996.

• 12) Nagata S: Apoptosis by death factor. Cell 88: 355-365, 1997.
  pubmed

• 13) Bredt DS and Snyder SH: Nitric oxide: a physio-logic messenger molecule. Annu. Rev,. Biochem.63: 175-195, 1994.

• 14) Takehara Y, Kanno T, Yoshioka T, et al: Oxygen-dependent regulation of mitochondrial energy metabolism by nitric oxide. Arch. Biochem. Biophys. 323: 27-32, 1995.
  pubmed

• 15) Asahi M, Fujii J, Suzuki K, et al: Inactivation of glutathione peroxidase by nitric oxide. J. Biol. Chem. 270: 21035-21039, 1995.
  pubmed

• 16)小林茂保, 田川邦夫: ミトコンドリア呼吸系の阻害剤. 蛋・核・酵 10: 1596-1609, 1965.

• 17) Garcia-Ruiz C, Colell A. Mari M, et al: Direct effect of ceramide on the mitochondrial electron transport chain leads to generation of reactive oxygen species. J. Biol. Chem.272 : 11369-11377, 1997.
  pubmed

• 18) Liu X, Kim CN, Yang J, et al: Induction of apoptotic program in cell-free extracts: Requirement for dATP and cytochrome c Cell 86: 147-157, 1996.
  pubmed

• 19) Recd JC: Cytochrome c: Can't live with it-Can't live without it. Cell 91: 559-562, 1997.

• 20) Little GH and Flores A: Inhibition of programed cell death by cyclosporin. Comp. Biochem Physiol. C. Biochem Mol. Biol. 103: 463-467, 1992.

• 21) Malkevitch NV, Dedukhova VI, Simonian RA, et al: Thyroxine induces cyclosporin A-insensitive. Ca2+-dependent reversible permeability transition pore in rat live rmitochondria. FEBS Lett.412: 173-178 ,1997.

• 22) Yabuki M, Inai Y, Yoshioka T, et al: Oxygen-dependent fragmentation of cellular DNA by nitric oxide. Free Radic. Res.26: 245-255, 1997.
  pubmed

• 23)Yabuki M, Kariya S, Inai Y. et al: Molecular mechanisms of apoptosis in HL-60 cells induced by a nitric oxide releasing compound. Free Radic. Res. 27: 325-335, 1997.
  pubmed

P.76 掲載の参考文献

• 1) Hoshida S, Yamas hita N Igarashi J, et al: Nitric oxide synthase protects the heart agaillst ischemia-reperfusion inj ury in rabbits.J. Pharmacol. Exp. Ther. 274: 413-418, 1995.

• 2) Hoshida S, Yamashita N, Igarashi J, et al: A nitric oxide donor reverses myocardial injury in rabbits with acute hypercholesterolemia.J. Pharmacol. Exp. Ther. 278: 741-746, 1996.
  pubmed

• 3) Hoshida S, Nishida M. Yamas hita N, et al: Amelioration of the severity of myocardial injury by anitric oxide donor in rabbits fed a cholesterol-rich diet. J. Am. Coll. Cardiol.27: 902-909, 1996.

• 4) Ishiyama S, Hiroe M. Nishikawa T, et al: Nitric oxide contributes to the progression of myocardial damage in experimental autoimmune myocarditis in rats. Circulation 95: 489-496, 1997.

• 5) Igarashi J, Nishida M, Hoshida S, et al: Inducible nitric oxide synthase augments injury elicited by oxidative stress in rat cardiac myocytes. Am. J. Physiol. 274: C245-C252, 1998.
  pubmed

• 6) Asahi M, Fujii J, Suzuki K, et al: Inactivation of glutathione peroxidase by nitric oxide. Implication for cytott) xicity. J. Biol. Chem. 70: 21035-21039, 1995.

• 7) de BA, Radomski MW. Why HJ, et al: Myocardial calcitun-independent nitric oxide synthase activity is present in dilated cardiomyopathy, myocarditis. and postpartum cardiomyopathy but not in ischaemic or valvar heart disease. Br. Heart. J.74: 426-430, 1995.
  pubmed

• 8) Habib FM, Springall DR, Davies GJ. et al: Tumour necrosis factor and inducible nitric oxide synthase in dilated cardiomyopathy. Lancet 347: 1151-1155, 1996.
  pubmed

• 9) Dhalla AK, Hill MF and Singal PK: Role of oxidative stress in transition of hypertrophy to heart failure. J. Am. Coll. Cardiol. 28: 506-514, 1996.
  pubmed

P.80 掲載の参考文献

• 1) Brown JF, Tepperman BL Hanson PJ. et al: Differential distribution on nitric oxide synthase between cell fractions isolated from the rat gastric mucosa. Biochem. Biophys. Res. Commun. 184: 680-685, 1992.
  pubmed

• 2) Lundberg J: Intragastric nitric oxidc production in humans: measurements in expelled air. Gut 35: 1543-1546, 1994.
  pubmed

• 3) Nishikawa M. Sato FM, Utsumi K. et al: Oxgen-dependent regulation of energy nietabolisni in ascites tumor cells by nitric oxide. Canser Res.56: 4535-4540, 1996.

• 4) Yu H, Sato EF. Nagata K, et al: Oxygen-dependent regulation of the respiration and growth of Escheria coli by nitric oxidc. FEBS Lett.409: 161-165, 1997.

• 5) Nakano M, Sugioka K, Ushijima Y, et al: Chemiluminescence with crypridina luciferin analog, 2-methyl-6-phenyl-3,7-dihydroimidazol [1,2-a] pyrazin-3-one, for estimation the ability of human granulocytes to generate O2.Anal. Biochem. 159: 363-369, 1986.

• 6) Akaike T, Yoshida M, Miyamoto Y, et al: Antagonistic action of imidazolincoxy N-oxidcs against endothelium-derived relaxing factor *NO through a radical reaction. Biochemistry 32: 827-832, 1993.
  pubmed

• 7) Brown GC: Hypothesis. Nitric oxide regulates mitochondrial respiration and cell functions by inhibiting cytochrome oxidase. FEBS Lett.369: 136-139, 1995.

• 8) Radi R, Rodriguez M, Castro J, et al: Inhibition of Imitochondrial electron transport by peroxynitrite. Arch Biochem. Biophys. 308: 89-95, 1994.

• 9) Epe B, Ballmaier D, Roussyn L et al: DNA damage by peroxinitrite characterized with DNA repair enzymes. Nucl. Acids. Res.24: 4105-4110,1996.

• 10) Blaser MJ: Genetic basis for heterogeneity of Helicobacter pylori. In Helicobacter pylori: Basic Mechanisms to Clinical Cure 1996 (cdited by Hunt RH and Tytgat GNJ) ,Kluwer Academic Publishers. The Netherlands, 1996. pp.33-39.